top of page
Human Inactivated Influenza A (H1N1) vaccine, Human I.P.

Generic Name: 

Human Inactivated Influenza A (H1N1) vaccine, Human I.P.


The H1N1 influenza virus vaccine is used to prevent infection with the 2009 Influenza A (H1N1) virus. Vaccines create your body's defenses (antibodies) against disease. Also called "flu vaccination". Influenza is a viral infection of the throat, bronchi and lungs. Influenza causes fever, chills, cough, headache, muscle aches, and back, arm, and leg pain.

This vaccine is an inactivated influenza A(H1N1) 2009 vaccine, a cell culture-derived vaccine manufactured using Madin-Darby Canine Kidney (MDCK) cells. Viruses are harvested from cell culture supernatants, clarified by microfiltration, inactivated, and purified by chromatography. Purified virus containing hemagglutinin and neuraminidase antigens is filter-sterilized.


After reconstitution, 0.5 mL contains.

H1N1 vaccine-Biovex.jpeg
H1N1 vaccine-Biovex.jpeg

Pharmaceutical Form:

Liquid vaccine for intramuscular injection.


Method of Administration:

Administered through Intramuscular injection.



0.5ml per dose


  • 0.5mL (Single dose) or 5mL (multi dose) liquid vaccine in a vial. 

  • 0.5mLPre-Filled Syringe.

Possible Side Effects:

Side effects are usually mild and disappear within a few days. Side effects of the flu vaccine include pain at the injection site, swelling, redness, headache, muscle aches, and fever.


Human inactivated influenza A (H1N1) should not be administered to individuals with a known history of severe hypersensitivity or life-threatening reaction to any component of the vaccine after prior administration of influenza vaccine.

Shelf Life:

24 months from date of manufacture.



Store at +2° C to +8° C.

bottom of page